0000899243-20-003354.txt : 20200205 0000899243-20-003354.hdr.sgml : 20200205 20200205175527 ACCESSION NUMBER: 0000899243-20-003354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200203 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hatzis-Schoch Brent CENTRAL INDEX KEY: 0001637054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 20580130 MAIL ADDRESS: STREET 1: C/O RADIUS HEALTH, INC. STREET 2: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-03 0 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001637054 Hatzis-Schoch Brent C/O BLACK DIAMOND THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 See Remarks Common Stock 2020-02-03 4 P 0 3000 19.00 A 3000 D On February 3, 2020, Reporting Person purchased 3,000 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering. Chief Operating Officer and General Counsel /s/ Brent Hatzis-Schoch 2020-02-05